METHODS FOR EVALUATING RESPONSE TO TREATMENT IN ADULT ACUTE LEUKEMIAFREIREICH EJ.1983; BLOOD CELLS; ISSN 0340-4684; DEU; DA. 1983; VOL. 9; NO 1; PP. 5-20; BIBL. 7 REF.Article

HISTORICAL CONTROLS REINCARNATED: AN EXAMINATION OF TECHNIQUES FOR CLINICAL THERAPEUTIC RESEARCHFREIREICH EJ; GEHAN EA.1974; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1974; VOL. 58; NO 5; PP. 623-626; BIBL. 1REF.Article

CANCER CLINICAL TRIALS. A RATIONAL BASIS FOR USE OF HISTORICAL CONTROLSGEHAN EA; FREIREICH EJ.1981; SEMIN. ONCOL.; ISSN 0093-7754; USA; DA. 1981; VOL. 8; NO 4; PP. 430-436; BIBL. 27 REF.Article

THE PLATELET FUNCTION PROFILE. A NEW FORMAT FOR RECORDING PLATELET FUNCTION TESTSROPER P; FREIREICH EJ.1979; AMER. J. CLIN. PATHOL.; USA; DA. 1979; VOL. 31; NO 3; PP. 338-340; BIBL. 7 REF.Article

RESPONSE TO CHRONIC LEUKAPHERESIS PROCEDURES AND SURVIVAL OF CHRONIC MYELOGENOUS LEUKEMIA PATIENTSHESTER JP; MCCREDIE KB; FREIREICH EJ et al.1982; TRANSFUSION (PHILA.); ISSN 0041-1132; USA; DA. 1982; VOL. 22; NO 4; PP. 305-307; BIBL. 7 REF.Article

IMPROVEMENT IN COMPLETE RESPONSE RATE, DURATION OF RESPONSE AND SURVIVAL WITH ADRIAMYCIN COMBINATION CHEMOTHERAPY FOR NON-HODGKIN LYMPHOMA: A PROGNOSTIC FACTOR COMPARISON OF TWO REGIMENSCABANILLAS F; RODRIGUEZ V; FREIREICH EJ et al.1978; MED. PEDIATR. ONCOL.; USA; DA. 1978; VOL. 4; NO 4; PP. 321-331; BIBL. 13 REF.Article

MANAGEMENT WITH CHEMOTHERAPY ONLY OF STAGE I AND II MALIGNANT LYMPHOMA OF AGGRESSIVE HISTOLOGIC TYPESCABANILLAS F; BODEY GP; FREIREICH EJ et al.1980; CANCER; ISSN 0008-543X; USA; DA. 1980; VOL. 46; NO 11; PP. 2356-2359; BIBL. 14 REF.Article

COMBINATION CHEMOTHERAPY IN VITRO. III. BCNUDREWINKO B; TI LI LOO; FREIREICH EJ et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 3; PP. 373-375; BIBL. 21 REF.Article

LETHAL ACTIVITY OF CAMPTOTHECIN SODIUM ON HUMAN LYMPHOMA CELLS = ACTION LETHALE DE LA CAMPTOTHECINE SODIQUE SUR LES CELLULES DES LYMPHOMES HUMAINSDREWINKO B; FREIREICH EJ; GOTTLIEB JA et al.1974; CANCER RES.; U.S.A.; DA. 1974; VOL. 34; NO 4; PP. 747-750; BIBL. 1/2P.Article

THE INFLUENCE OF A NEW ANALGETIC-ANTIPHLOGISTIC COMPOUND (2-(2-METHYL-3PRIME CHLORO)-ANILINO-NICOTINIC ACID) ON PLATELET FUNCTION AND FIBRINOLYTIC ACTIVITY IN VITRO = INFLUENCE D'UN NOUVEAU COMPOSE ANALGESIQUE ET ANTI-INFLAMMATOIRE (ACIDE 2-(2-METHYL-3PRIME CHLORO)-ANILINO-NICOTINIQUE) SUR LA FONCTION PLAQUETTAIRE ET L'ACTIVITE FIBRINOLYTIQUE IN VITROWIDMER K; REED RC; FREIREICH EJ et al.1975; THROMBOSIS RES.; G.B.; DA. 1975; VOL. 6; NO 1; PP. 9-17; BIBL. 18REF.Article

THE EFFECT OF ADRIAMYCIN ON THE CELL CYCLE TRAVERSE OF A HUMAN LYMPHOID CELL LINE.BARLOGIE B; DREWINKO B; JOHNSTON DA et al.1976; CANCER RES.; U.S.A.; DA. 1976; VOL. 36; NO 6; PP. 1975-1979; BIBL. 23 REF.Article

MODULATION OF 9-BETA -D-ARABINOFURANOSYLADENINE 5'-TRIPHOSPHATE AND DEOXYADENOSINE TRIPHOSPHATE IN LEUKEMIC CELLS BY 2'-DEOXYCOFORMYCIN DURING THERAPY WITH 9-BETA -D-ARABINOFURANOSYLADENINEPLUNKETT W; BENJAMIN RS; KEATING MJ et al.1982; CANCER RES.; ISSN 0008-5472; USA; DA. 1982; VOL. 42; NO 5; PP. 2092-2096; BIBL. 32 REF.Article

INITIAL CLINICAL STUDIES WITH BRUCEANTINBEDIKIAN AY; VALDIVIESO M; BODEY GP et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 11-12; PP. 1843-1847; BIBL. 3 REF.Article

NODULAR MALIGNANT LYMPHOMAS. FACTORS AFFECTING COMPLETE RESPONSE RATE AND SURVIVALCABANILLAS F; SMITH T; BODEY GP et al.1979; CANCER; USA; DA. 1979; VOL. 44; NO 6; PP. 1983-1989; BIBL. 15 REF.Article

A PHASE 1 AND 2 TRIAL OF RUBIDAZONE IN PATIENTS WITH ACUTE LEUKEMIA.BENJAMIN RS; KEATING MJ; MCCREDIE KB et al.1977; CANCER RES.; U.S.A.; DA. 1977; VOL. 37; NO 12; PP. 4623-4628; BIBL. 27 REF.Article

INCREASED GRANULOCYTE COLLECTION WITH THE BLOOD CELL SEPARATOR AND THE ADDITION OF ETIOCHOLANOLONE AND HYDROXYETHYL STARCH = AUGMENTATION DU RECUEIL DE GRANULOCYTES AVEC LE SEPARATEUR DE CELLULES DU SANG ET L'ADDITION D'ETIOCHOLANOLONE ET D'HYDROXY-ETHYLAMIDONMCCREDIE KB; FREIREICH EJ; HESTER JP et al.1974; TRANSFUSION; U.S.A.; DA. 1974; VOL. 14; NO 4; PP. 357-364; BIBL. 19REF.Article

PHASE I STUDY OF AZIRIDINYLBENZOQUINONE (NSC 182986)BEDIKIAN AY; BODEY GP; BURGESS MA et al.1981; CANCER CLIN. TRIALS; ISSN 0190-1206; USA; DA. 1981; VOL. 4; NO 4; PP. 459-463; BIBL. 10 REF.Article

CELL CYCLE PHASE-SPECIFIC CYTOTOXICITY OF THE ANTITUMOR AGENT MAYTANSINERAO PN; FREIREICH EJ; SMITH ML et al.1979; CANCER RES.; USA; DA. 1979; VOL. 39; NO 8; PP. 3152-3155; BIBL. 12 REF.Article

FREQUENCY OF HLA ANTIGENS IN CHRONIC MYELOCYTIC LEUKEMIA.HESTER JP; ROSSEN R; TRUJILLO J et al.1977; SOUTH. MED. J.; U.S.A.; DA. 1977; VOL. 70; NO 6; PP. 691-693; BIBL. 15 REF.Article

IMVP-16: AN EFFECTIVE REGIMEN FOR PATIENTS WITH LYMPHOMA WHO HAVE RELAPSED AFTER INITIAL COMBINATION CHEMOTHERAPYCABANILLAS F; HAGEMEISTER FB; BODEY GP et al.1982; BLOOD; ISSN 0006-4971; USA; DA. 1982; VOL. 60; NO 3; PP. 693-697; BIBL. 23 REF.Article

PREDICTION OF REMISSION IN ADULT ACUTE LEUKEMIA: DEVELOPMENT AND TESTING OF PREDICTIVE MODELSSMITH TL; GEHAN EA; KEATING MJ et al.1982; CANCER; ISSN 0008-543X; USA; DA. 1982; VOL. 50; NO 3; PP. 466-472; BIBL. 16 REF.Article

DOSE-DEPENDENT SUPPRESSION OF DNA SYNTHESIS IN VITRO AS A PREDICTOR OF CLINICAL RESPONSE IN ADULT ACUTE MYELOBLASTIC LEUKEMIADOSIK GM; BARLOGIE B; JOHNSTON D et al.1981; EUR. J. CANCER; ISSN 0014-2964; GBR; DA. 1981; VOL. 17; NO 5; PP. 549-555; BIBL. 34 REF.Article

INITIAL EXPERIENCE WITH AMSA AS SINGLE AGENT TREATMENT AGAINST MALIGNANT LYMPHOPROLIFERATIVE DISORDERSCABANILLAS F; LEGHA SS; BODEY GP et al.1981; BLOOD; ISSN 0006-4971; USA; DA. 1981; VOL. 57; NO 3; PP. 614-616; BIBL. 9 REF.Article

PROTECTED ENVIRONMENT-PROPHYLACTIC ANTIBIOTIC PROGRAM FOR MALIGNANT LYMPHOMA: RANDOMIZED TRIAL DURING CHEMOTHERAPY TO INDUCE REMISSIONBODEY GP; RODRIGUEZ V; CABANILLAS F et al.1979; AMER. J. MED.; USA; DA. 1979; VOL. 66; NO 1; PP. 74-81; BIBL. 18 REF.Article

TREATMENT OF ACUTE LEUKEMIA IN PROTECTED ENVIRONMENT UNITSBODEY GP; MCCREDIE KB; KEATING MJ et al.1979; CANCER; USA; DA. 1979; VOL. 44; NO 2; PP. 431-436; BIBL. 18 REF.Article